AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition. (Q38597474)
Jump to navigation
Jump to search
scientific article published on 25 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition. |
scientific article published on 25 January 2010 |
Statements
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition (English)
L Santo
S Vallet
T Hideshima
D Cirstea
H Ikeda
Y Okawa
G Gorgun
E Calabrese
M Yule
M Squires
M Boccadoro
P G Richardson
N C Munshi
K C Anderson
25 January 2010
1 reference